Generic medicine
Cephalexin
Cephalexin · ATC J01DB · Anti-infectives · First-generation cephalosporins
Data statusRegistration & price fields require source verification.
58brand families
173registered presentations
49companies
173with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.| Brand | Manufacturer | Registered presentations |
|---|---|---|
| Lexin2 presentations | IRZA PHARMA (PVT) LTD | |
| Lexofin Suspention2 presentations | Himedic Pharmaceuticals Pvt Ltd | |
| Maclexin2 presentations | Mass Pharma (Pvt) Ltd. | |
| Monolexin2 presentations | Pearl Pharmaceuticals | |
| Mucaceph1 presentation | Raazee Therapeutics (Pvt Ltd. |
|
| MURBEX2 presentations | OPAL LABORATORIES (PVT) LTD | |
| Ospexin2 presentations | Herbion Pakistan (Pvt.) Ltd. | |
| Perlex2 presentations | Nicholas Pharmaceuticals | |
| Retaphal3 presentations | Arreta Pharmaceuticals (Pvt.) Ltd. | |
| RG-Cin1 presentation | Regal Pharmaceuticals |
|
| Safe Pharmaceuticals (Pvt) Ltdlexin2 presentations | SAFE PHARMACEUTICAL (PVT) LTD | |
| Selexin2 presentations | Semos Pharmaceuticals PVT LTD | |
| Solexin2 presentations | Pharmasol (Pvt) Ltd. | |
| Truscot2 presentations | Scotmann Pharmaceuticals | |
| Xesafin Dry Susp1 presentation | Himont Pharmaceuticals (Pvt.) Ltd. |
|
| Xesafin Susp1 presentation | Himont Pharmaceuticals (Pvt.) Ltd. |
|
| Zafalexin2 presentations | Zafa Pharmaceutical Laboratories (Pvt) Ltd. |
Price movement
Official price changes for Cephalexin
23 official price changes across 173 tracked presentations since 1 Jul 2024; median change +4.9%; largest +4.9% (Cerox 125 mg/5 mL)
Each dot is one DRAP-notified price change for one pack. Amber: increase; teal: decrease. Hover or tap for detail; click to open the brand.
| Brand | Pack | Effective | Old to new | Change |
|---|---|---|---|---|
| Cerox 125 mg/5 mL | 60ml | 20 Aug 2026 | PKR 117.44 to 123.25 | +4.9% |
| B-Lex 125 mg/5 mL | 60ml | 17 Aug 2026 | PKR 125.18 to 131.37 | +4.9% |
| Kephalexin 250 mg | 1x12's | 17 Aug 2026 | PKR 155.76 to 163.46 | +4.9% |
| Kephalexin 125 mg/5 mL | 60ml | 17 Aug 2026 | PKR 99.15 to 104.05 | +4.9% |
| B-Lex 250 mg | 12's | 17 Aug 2026 | PKR 157.03 to 164.79 | +4.9% |
| Maclexin 125 mg/5 mL | 60ml | 20 Aug 2026 | PKR 76.70 to 80.49 | +4.9% |
| Delexin 250 mg | 12's | 17 Aug 2026 | PKR 193.88 to 203.46 | +4.9% |
| Delexin 250 mg/5 mL | 60 mL | 17 Aug 2026 | PKR 193.88 to 203.46 | +4.9% |
| Kephalexin 500 mg | 1x12's | 17 Aug 2026 | PKR 304.65 to 319.70 | +4.9% |
| B-Lex 500 mg | 12's | 17 Aug 2026 | PKR 310.13 to 325.45 | +4.9% |
Showing the 10 largest of 23 changes. Every change is also on its brand page.
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.
Cite this record
Molecule record · ATC J01DBMedInfoBase. (2026). Cephalexin — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/cephalexin/ ATC J01DB.
MedInfoBase. Cephalexin — registered brands and price distribution in Pakistan [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 24]. Available from: https://medinfobase.com/generic/cephalexin/ ATC J01DB.
MedInfoBase (2026) Cephalexin — registered brands and price distribution in Pakistan. Available at: https://medinfobase.com/generic/cephalexin/ (Accessed: 24 September 2026).
"Cephalexin — registered brands and price distribution in Pakistan." MedInfoBase, 2026, https://medinfobase.com/generic/cephalexin/. Accessed 24 Sep 2026.
MedInfoBase. 2026. "Cephalexin — registered brands and price distribution in Pakistan." Accessed September 24, 2026. https://medinfobase.com/generic/cephalexin/.
Records change over time. Please cite the access date so readers can locate the version you used.
